XML 40 R28.htm IDEA: XBRL DOCUMENT
v3.22.0.1

COVID-19 Developments | 12 Months Ended
--- | ---
Dec. 31, 2021
C O V I D19 Developments [Abstract] |
COVID-19 Developments | Note 21 – COVID-19 Developments In December 2019, COVID-19 surfaced and in March 2020, the World Health Organization declared a pandemic related to the rapid spread of COVID-19 around the world. The impact of the COVID-19 outbreak on the businesses and the economy in the U.S. and the rest of the world is, and is expected to continue to be, uncertain and may continue to be significant. Accordingly, the Company cannot predict the extent to which its financial condition and results of operation will be affected. On March 17, 2020, the Company suspended most of its production and non-essential business locations where employees can work from home. A very limited number of manufacturing personnel remained at work for critical late staged processes, until the end of March 2020. Manufacturing resumed on April 27, 2020. The Company’s revenues have been adversely impacted, and the Company experienced a substantial slowdown in sales beginning March 20, 2020 in global geographies characterized as “hot spots” for the COVID-19 virus, including parts of Europe, North America, Asia, the Middle East and India. In certain of these markets, sales have paused as elective surgeries are discouraged to support COVID-19 related needs. The Company continues to monitor the commercial and operational impact of new variants of COVID-19 in its markets.

X
- Definition COVID-19 developments. + References No definition available. + Details
Name: | staa_COVID19DevelopmentsAbstract
Namespace Prefix: | staa_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition COVID- 19 developments. + References No definition available. + Details
Name: | staa_Covid19DevelopmentsTextBlock
Namespace Prefix: | staa_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration